GABAPENTIN 250 MG/5 ML SOLN
For 1 mL
Pharmacies pay
$0.09 – $0.17 filed
1 × $0.08761 to $0.1712 per ML (the 8 NDCs differ)
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-02-18, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$5.10 – $5.20 estimated
NADAC for the pack + 15% + $5.00 fee per fill
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-02-18, 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
GABAPENTIN 250 MG/5 ML SOLN is how the CMS NADAC file names this product. The FDA NDC Directory lists it as gabapentin.
FDA gives its dosage form as “solution” and “suspension” and its route as oral.
FDA lists 8 labelers (the companies named on the label) for its NDCs, among them PAI Holdings, LLC dba PAI Pharma, Camber Pharmaceuticals, Inc. and Acella Pharmaceuticals, LLC.
FDA lists no Established Pharmacologic Class for it.
The NADAC file of 2026-10-14 prices it under 8 NDCs (National Drug Codes).
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $0.09 – $0.17 for 1 mL, depending on the NDC ($0.08761 to $0.1712 per ML), by the CMS NADAC file of 2026-10-14; those prices took effect between 2026-02-18 and 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 4, carried forward from the previous file; 5, calculated based on package size; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.
The NADAC of 1 of these 8 NDCs was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: it took effect on 2026-02-18. The file is new; the price is not.
What NADAC measures · NADAC explanation codes · Carried-forward prices
The 8 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Acella Pharmaceuticals, LLC | 1 | $0.08761 per ML filed |
| Advagen Pharma Ltd | 1 | $0.08761 per ML filed |
| Ajenat Pharmaceuticals LLC | 1 | $0.08761 per ML filed |
| Amneal Pharmaceuticals LLC | 1 | $0.1712 per ML filed |
| BioComp Pharma, Inc. | 1 | $0.08761 per ML filed |
| Camber Pharmaceuticals, Inc. | 1 | $0.08761 per ML filed |
| Mylan Pharmaceuticals Inc. | 1 | $0.08761 per ML filed |
| PAI Holdings, LLC dba PAI Pharma | 1 | $0.08761 per ML filed |
When these prices took effect
- 2026-09-23 · 7 NDCs · $0.08761 per ML filed
- 2026-02-18 · 1 NDC, carried forward from an earlier file · $0.1712 per ML filed
All 8 NDCs, with labeler and price
- 00121-1067-16 · PAI Holdings, LLC dba PAI Pharma · $0.08761 per ML · eff. 2026-09-23 filed
- 31722-0069-47 · Camber Pharmaceuticals, Inc. · $0.08761 per ML · eff. 2026-09-23 filed
- 42192-0608-16 · Acella Pharmaceuticals, LLC · $0.08761 per ML · eff. 2026-09-23 filed
- 44523-0120-16 · BioComp Pharma, Inc. · $0.08761 per ML · eff. 2026-09-23 filed
- 59762-5050-07 · Mylan Pharmaceuticals Inc. · $0.08761 per ML · eff. 2026-09-23 filed
- 65162-0698-90 · Amneal Pharmaceuticals LLC · $0.1712 per ML · eff. 2026-02-18 filed carried forward
- 72888-0104-25 · Advagen Pharma Ltd · $0.08761 per ML · eff. 2026-09-23 filed
- 82983-0423-47 · Ajenat Pharmaceuticals LLC · $0.08761 per ML · eff. 2026-09-23 filed
Other strengths, forms and brands
20 other products in the NADAC file share the FDA nonproprietary name gabapentin with GABAPENTIN 250 MG/5 ML SOLN.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| GABAPENTIN 100 MG CAPSULE | $0.02184 per EA filed | $0.1192 per EA filed |
| GABAPENTIN 250 MG/5 ML SOLN this page | $0.08761 to $0.1712 per ML filed | We don’t know yet |
| GABAPENTIN 300 MG CAPSULE | $0.03142 per EA filed | $0.1192 per EA filed |
| GABAPENTIN 400 MG CAPSULE | $0.04222 per EA filed | $0.1192 per EA filed |
| GABAPENTIN 600 MG TABLET | $0.06398 per EA filed | $0.1192 per EA filed |
| GABAPENTIN 800 MG TABLET | $0.08829 per EA filed | $0.1192 per EA filed |
| GABAPENTIN ER 300 MG TABLET | $0.63846 per EA filed | $5.0138 per EA filed |
| GABAPENTIN ER 600 MG TABLET | $1.02497 per EA filed | $5.0138 per EA filed |
| GABARONE 100 MG TABLET | $8.78889 per EA filed | We don’t know yet |
| GABARONE 400 MG TABLET | $8.57111 per EA filed | We don’t know yet |
| GRALISE ER 300 MG TABLET | $10.18511 per EA filed | We don’t know yet |
| GRALISE ER 450 MG TABLET | $10.14274 per EA filed | We don’t know yet |
| GRALISE ER 600 MG TABLET | $10.15306 per EA filed | We don’t know yet |
| GRALISE ER 900 MG TABLET | $15.20748 per EA filed | We don’t know yet |
| NEURONTIN 100 MG CAPSULE | $2.95761 per EA filed | $8.87549 per EA filed |
| NEURONTIN 300 MG CAPSULE | $7.37105 per EA filed | $8.87549 per EA filed |
| NEURONTIN 400 MG CAPSULE | $8.86718 per EA filed | $8.87549 per EA filed |
| NEURONTIN 600 MG TABLET | $14.11861 per EA filed | $8.87549 per EA filed |
| NEURONTIN 800 MG TABLET | $16.88137 per EA filed | $8.87549 per EA filed |
| RELGAABI 300 MG CAPSULE | $0.03142 per EA filed | $0.1192 per EA filed |
| RELGAABI 400 MG CAPSULE | $0.04222 per EA filed | $0.1192 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. between 2025-12-17 and 2026-09-23 (4 dates) · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 1 mL? Is it lower than what I would pay through my insurance?
- Which NDC (the 11-digit number on the package) is this? Pharmacies pay $0.08761 to $0.1712 per ML for this product, depending on the NDC.
- How much is in the package I am getting? This page uses 1 mL; your package may hold a different amount.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why does this page start at 1 mL?
- The FDA package descriptions of this product’s NDCs give different amounts (470 mL, 473 mL). So the card starts at 1 ML; change it to match your prescription.